MedPath

BLACKMORES BIO ZINC PLUS ADVANCED TABLET

Registration Number: MAL25046093NCR

Approved
Approval ID

dfb8d9551a122d4b

Registration Number

MAL25046093NCR

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types10 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (10)

10 TabletsAvailable
Package Size: 10 Tablets
Status: NPRA Approved
15 TabletsAvailable
Package Size: 15 Tablets
Status: NPRA Approved
20 TabletsAvailable
Package Size: 20 Tablets
Status: NPRA Approved
30 TabletsAvailable
Package Size: 30 Tablets
Status: NPRA Approved
60 TabletsAvailable
Package Size: 60 Tablets
Status: NPRA Approved
90 TabletsAvailable
Package Size: 90 Tablets
Status: NPRA Approved
100 TabletsAvailable
Package Size: 100 Tablets
Status: NPRA Approved
120 TabletsAvailable
Package Size: 120 Tablets
Status: NPRA Approved
150 TabletsAvailable
Package Size: 150 Tablets
Status: NPRA Approved
180 TabletsAvailable
Package Size: 180 Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (5)

Retinyl Acetate (Vitamin A)Active
Monograph: retinyl acetate (vitamin a)
ZINC AMINO ACID CHELATEActive
Monograph: Amino acid
MAGNESIUM OXIDE HEAVYActive
Monograph: Magnesium oxide
MANGANESE AMINO ACID CHELATEActive
Monograph: manganese amino acid chelate
MAGNESIUM PHOSPHATE PENTAHYDRATEActive
Monograph: magnesium phosphate pentahydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BLACKMORES BIO ZINC PLUS ADVANCED TABLET - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform